Haplotype distribution of the apolipoprotein B gene in Korean essential hypertensives

Korean Journal of Genetics

Volumn 24, Issue 1, 2002, Pages 67-74

  Kang, Byung Yong ^a   Lee, Kang Oh ^a   Bae, Joon Seol ^b   Kim, Ki Tae ^b   Shin, Jung Hee ^c   Lee, Chung Choo ^c,d  

^a Sahmyook University   (South Korea)

^b Seoulin Bioscience Co Ltd   (South Korea)

^c Seoul National University   (South Korea)

^d Gachon University   (South Korea)

Author keywords

Apolipoprotein B; Essential hypertension; Haplotype

Indexed keywords

APOLIPOPROTEIN B;

ADULT; AGED; ALLELE; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; ESSENTIAL HYPERTENSION; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENOTYPE; HAPLOTYPE; HUMAN; KOREA; MAJOR CLINICAL STUDY; MARKER GENE; POPULATION DISTRIBUTION; POPULATION GENETICS; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

EID: 0036113404     PISSN: 02545934     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Bae JS, Kang BY, Kim KT, Shin JH and Lee CC (2001) Association study on the genetic variation of the dopamine D1 receptor gene in Korean essential hypertensives. Korean J. Genetics 23(3): 221-226.
2. Berg, K (1986) DNA polymorphism at the apolipoprotein B locus is associated with lipoprotein level. Clin Genet 30: 515-520.
3. Bostein D, White RL, Skolnick M and Davis RW (1980) Construction of a genetic linkage map in man using restriction fragment length polymorphisms. Am J Hum Genet 32: 314-331.
4. Brown MS and Goldstein JL (1986) A receptor-mediated pathway for cholesterol homeostasis. Science 232: 34-47.
5. Brunzell JD, Sniderman AD, Albers JJ and Kwiterovich PO (1984) Apolipoprotein B and A-I and coronary artery disease in humans. Arteriosclerosis 4: 79-83.
6. Catalano M, Aronica A, Carzaniga G, Seregni R and Libretti A (1991) Serum lipids and apolipoproteins in patients with essential hypertension. Atherosclerosis 87: 17-22.
7. Chen SH, Yang CY, Chen PF, Stezer D, Tanimura M, Li WH, Gotto AM Jr and Chan L (1986) The complete cDNA and amino acid sequence of human apolipoprotein B-100. J Biol Chem 261: 12918-12921.
8. Cooper RS and Rotimi C (1994) Hypertension in blacks: is a genetic susceptibility ? J Hypertens 12: 215-227.
9. Ferns GA, Robinson J and Galton DJ (1988) DNA haplotypes of the human apolipoprotein B gene in coronary atherosclerosis. Hum Genet 81: 76-80.
10. Friedwald WT, Levy RI and Fridrickson DS (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma without the use of the preparative ultracentrifuge. Clin Chem 18: 499-502.
11. Frossard PM, Obineche EN and Lestringant GG (1999) Association of an apolipoprotein B gene marker with essential hypertension. Hypertension 33: 1052-1056.
12. Fuh MMT, Shieh SM, Wu DA, Chen YDI and Reaven GM (1987) Abnormalities of carbohydrate and lipid metabolism in patients with hypertension. Arch Intern Med 147: 1035-1038.
13. Genest JJ, Ordovas JM Jr, McNamara JR, Robins AM, Meade T, Cohn SD, Salem DN, Wilson PWF, Masharani U and Schaefer EJ (1990) DNA polymorphisms of the apolipoprotein B gene in patients with premature coronary artery disease. Atherosclerosis 82: 7-11.
14. Hegele RA, Brunt JH and Connelly PW (1996) Genetic and Biochemical factors associated with variation in blood pressure in a genetic isolate. Hypertension 27: 308-312.
15. Hegele RA, Huang LS, Herbert PN, Blum CB, Buring JE, Hennekens CH and Breslow JL (1986) Apolipoprotein B-gene DNA polymorphisms associated with myocardial infarction. N Engl J Med 315: 1509-1515.
16. Higashimori K, Higaki J, Miki, T, Kamitani A, Mikami H, Kumahara Y and Ogihara T (1992) Analysis of the apolipoprotein B 3'hypervariable region in patients with essential hypertension. Clin Exp Pharmacol Physiol 19(Suppl. 20): 21-23.
17. Hill WG and Robertson A (1968) Linkage disequilibrium of finite populations. Theor Appl Genet 38: 226-231.
18. Hong SS, Kim UK, Chae JJ, Goh SS, Kim YS, Namkoong Y, Park JE, Kim KS, Hong SE and Lee CC (1995) Lack of correlation between DNA polymorphisms of the apoB gene and plasma lipid levels in Korean population. Mol Cells 5: 235-242.
19. Hong SH, Song JH and Kim JQ (2001) The haplotype analyses using multiple markers of the apolipoprotein B gene in patients with coronary artery disease. J. Korean Med Sci 16: 719-724.
20. Hunt SC, Wu LL, Hopkins PN, Stults BM, Kuida H, Ramirez ME, Lalouel JM and Williams RR (1989) Apolipoprotein, low density lipoprotein subfraction, and insulin associations with familial combined hyperlipidemia. Study of Utah patients with familial dyslipidemic hypertension. Arteriosclerosis 9: 335-344.
21. Law SW, Lakner KJ, Hospattanker AV, Anchors JM, Sakaguchi AY, Naylor SL and Brewer HB (1985) Human apolipoproteinB-100: cloning, analysis of liver mRNA and assignment of the gene to chromosome 2. Proc Natl Acad Sci USA 82: 8340-8344.
22. Law A, Wallis SC, Powell LM, Pease RJ, Brunt H, Priestley LM, Knott TJ, Scott J, Altman DG and Miller GJ (1986) Common DNA polymorphism within coding sequence of apolipoprotein B gene associated with altered lipid levels. Lancet 1: 1301-1302.
23. Lee, C and Hong JH (2001) Y chromosomal heterogeneity of six tetrameric microsatellites in a Korean population. Korean J. Genetics 23(1): 13-20.
24. Lewontin RC (1964) The interaction of selection and linkage. I. General considerations: heterotic models. Genetics 49: 49-67.
25. Li WH, Tanimura M, Luo CC, Datta S and Chan L (1988) The apolipoprotein multigene family: biosynthesis, structure, structure-function relationships and evolution. J Lipid Res 29: 245-271.
26. Ludwig EH and McCarthy BJ (1990) Haplotype analysis of the human apolipoprotein B mutation associated with familial defective apolipoprotein B100. Am J Hum Genet 47: 712-720.
27. Monslave MV, Young R, Jobsis J, Wiseman SA, Dhamu S, Powell JT, Greenhalgh RM and Humphries SE (1988) DNA polymorphisms of the gene for apolipoprotein B in patients with peripheral arterial diasease. Atherosclerosis 70: 123-129.
28. Myant NB, Gallagher J, Barbir M, Thompson GR, Wile D and Humphries SE (1989) Restriction fragment length polymorphism in the apo B gene in relation to coronary artery disease. Atherosclerosis 71: 193-201.
29. Pisarska M (1996) Polymorphic variability of apolipoprotein B and insulin receptor genes in essential hypertension. Pol Arch Med Wewn 95: 205-211.
30. Renges HH, Peacock R, Dunning AM, Talmud P and Humphries SE (1992) Genetic relationship between the 3′-VNTR and diallelic apolipoprotein B gene polymorphism: Haplotype analysis in individuals of European and South Asian origin. Ann Hum Genet 56: 11-33.
31. Sambrook J, Fritsch EF and Maniatis T (1989) Molecular cloning: a Laboratory Manual. 2nd Ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, pp 9.16-9.23.
32. Selby JV, Newman B, Quiroga J, Christian JC, Austin MA and Fabsitz RR (1991) Concordance for dyslipidemic hypertension in male twins. JAMA 265: 2079-2084.
33. Sham PC and Curtis D (1995) Monte Carlo tests for associations between diseases and alleles at highly polymorphic loci. Ann Hum Genet 59: 97-105.
34. Shieh SM, Shen M, Fuh MM, Chen YD and Reaven GM (1987) Plasma lipid and lipoprotein concentrations in Chinese males with coronary artery disease, with and without hypertension. Atherosclerosis 67: 49-55.
35. Visvikis S, Chan L, Siest G, Drouin P and Boerwinkle E (1990) An insertion deletion polymorphism in the signal peptide of the human apolipoprotein B gene. Hum Genet 84: 373-375.
36. Williams RR, Hunt SC, Hasstedt SJ, Hopkins PN, Wu LW, Berry TD, Stults BM, Barlow GK, Schumacher MC and Kuida H (1989) Current knowledge regarding the genetics of human hypertension. J Hypertens Suppl 7: S8-S13.